REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS

被引：0
|
作者：
Garris, C. [1 ]
Dhir, S. [1 ]
Waller, J. [2 ]
Roberts, J. [2 ]
Mycock, K. [2 ]
Oglesby, A. [1 ]
Collins, B. [1 ]
Dominguez, M. [1 ]
Pike, J. [2 ]
Mrus, J. M. [1 ]
机构：
[1] ViiV Healthcare, Res Triangle Pk, NC USA
[2] Adelphi Real World, Bollington, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.879
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN5
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [41] Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care Settings
    Nance, Robin M.
    Vannappagari, Vani
    Smith, Kimberly
    Johannes, Catherine B.
    Calingaert, Brian
    Saltus, Catherine W.
    Mayer, Kenneth H.
    Whitney, Bridget M.
    Rodriguez, Benigno
    Moore, Richard D.
    Eron, Joseph J.
    Geng, Elvin
    Mathews, William Christopher
    Mugavero, Michael J.
    Saag, Michael S.
    Kitahata, Mari M.
    Delaney, Joseph A. C.
    Crane, Heidi M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (05) : 572 - 577
  • [42] The DOL-ART cohort: providing evidence from real-world data - use of dolutegravir-based regimens in routine clinical care in Germany
    Postel, Nils
    Mueller, Markus
    Wyen, Christoph
    Brust, Juergen
    Stoehr, Albrecht
    Glaunsinger, Tobias
    Scholten, Stefan
    Rausch, Michael
    Westermayer, Bernd
    Herrmann, Martina
    Walli, Ravi Kumar
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [43] Challenges of scale-up to dolutegravir-based regimens in sub-Saharan Africa
    Salou, Mounerou
    Butel, Christelle
    Comlan, Adjo S.
    Konou, Abla A.
    Tegueni, Kokou
    Ehlan, Amivi
    Lack, Fiali
    Dossim, Sika
    Ayouba, Ahidjo
    Delaporte, Eric
    Dagnra, Anoumou Y.
    Peeters, Martine
    AIDS, 2020, 34 (05) : 783 - 787
  • [44] Two-drug HIV regimens: more data still needed
    Masters, Mary Clare
    Cohn, Susan Ellen
    LANCET HIV, 2021, 8 (08): : E454 - E455
  • [45] Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients
    Nasreddine, Rakan
    Florence, Eric
    Vandercam, Bernard
    Moutschen, Michel
    Goffard, Jean-Christophe
    de Munter, Paul
    Delforge, Marc
    Marinus, Wouter
    De Wit, Stephane
    AIDS, 2020, 34 (08) : 1151 - 1159
  • [46] Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
    Duenas-Gutierrez, Carlos
    Buzon, Luis
    Pedrero-Tome, Roberto
    Iribarren, Jose A.
    De los Santos, Ignacio
    De la Fuente, Sara
    Pousada, Guillermo
    Moran, Miguel Angel
    Moreno, Estela
    Ferreira, Eva
    Gomez, Julia
    Troya, Jesus
    VIRUSES-BASEL, 2023, 15 (04):
  • [47] Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting
    Deschanvres, Colin
    Reynes, Jacques
    Lamaury, Isabelle
    Rey, David
    Palich, Romain
    Bani-Sadr, Firouze
    Robineau, Olivier
    Duvivier, Claudine
    Hocqueloux, Laurent
    Cuzin, Lise
    Joly, Veronique
    Raffil, Francois
    Cabie, Andre
    Allavena, Clotilde
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (01) : 196 - 204
  • [48] Systematic literature review of real-world experience with the two-drug regimen dolutegravir and lamivudine in people with HIV who would not have met inclusion criteria for the phase III clinical program
    Slim, J.
    Ward, D.
    Schneider, S.
    Kabra, M.
    Verdier, G.
    Jones, B.
    Letang, E.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 86 - 88
  • [49] Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients
    Galizzi, Nadia
    Poli, Andrea
    Galli, Laura
    Muccini, Camilla
    Mastrangelo, Andrea
    Dell'Acqua, Raffaele
    Maillard, Myriam
    Bossolasco, Simona
    Cinque, Paola
    Lazzarin, Adriano
    Castagna, Antonella
    Gianotti, Nicola
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (03)
  • [50] Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial
    Jamieson, Lise
    Serenata, Celicia
    Makhubele, Lebogang
    Sokhela, Simiso
    Mashabane, Nkuli
    Akpomiemie, Godspower
    Johnson, Leigh F.
    Venter, Willem D. F.
    Meyer-Rath, Gesine
    AIDS, 2021, 35 : S173 - S182
12345